PTAB Upholds DNA Sequencing Patent, Strengthening University of Washington’s Biotech Position
In a significant decision for the biotechnology sector, the Patent Trial and Appeal Board (PTAB) has once again ruled against Guardant Health, affirming the validity of claims in a DNA sequencing patent held by the University of Washington. This ruling maintains the integrity of the original $245 million infringement judgment linked to the patent dispute,…